43 studies found for:    " June 09, 2010":" July 09, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
Intervention:
22 Completed Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Candida albicans Skin Test Antigen
23 Recruiting Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users
Condition: HIV Infections
Interventions: Behavioral: HIV Testing and Counseling;   Behavioral: Contingency Management;   Behavioral: Strengths-based case management
24 Unknown  Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Condition: HIV Positive
Intervention:
25 Not yet recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
26 Unknown  Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
Condition: HIV Infection
Intervention: Biological: Adjuvanted vaccine against H1N1 influenza virus (GSK)
27 Unknown  Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
Condition: HIV Infections
Intervention: Behavioral: cell phone sms text messaging
28 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density
Condition: HIV
Intervention: Drug: Switch from tenofovir to abacavir
29 Terminated Gene Transfer for HIV Using Autologous T Cells
Condition: HIV-1 Infection
Intervention: Genetic: pHIV7-shI-TAR-CCR5RZ treated CD4 cells
30 Completed Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda
Condition: HIV Infection
Interventions: Behavioral: Invitation letter for male spouse;   Behavioral: Information letter
31 Terminated MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)
Condition: HIV-1 Infection
Interventions: Drug: MK6186;   Drug: Comparator: Placebo
32 Completed Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
Conditions: HIV Positive;   Herpes Simplex, Genital
Intervention:
33 Active, not recruiting RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
Condition: HIV Positive
Intervention:
34 Completed
Has Results
A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine
Condition: HIV Infection
Intervention:
35 Completed A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
36 Active, not recruiting Intense Acute Infection Study
Condition: Acute HIV Infection
Interventions: Drug: raltegravir;   Drug: maraviroc;   Drug: emtricitabine 200mg /tenofovir 300mg;   Drug: lopinavir 400 mg/ritonavir 100mg
37 Completed Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults
Condition: HIV-1 Infections
Interventions: Biological: ChAdV63.HIVconsv low dose.;   Biological: ChAdV63.HIVconsv high dose.;   Biological: pSG2.HIVconsv;   Biological: MVA.HIVconsv;   Other: Placebo
38 Completed RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Adult Grade III Lymphomatoid Granulomatosis;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Primary CNS Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   HER2-negative Breast Cancer;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Male Breast Cancer;   Nodal Marginal Zone B-cell Lymphoma;   Post-transplant Lymphoproliferative Disorder;   Primary Central Nervous System Hodgkin Lymphoma;   Primary Central Nervous System Non-Hodgkin Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Rectal Cancer;   Recurrent Small Lymphocytic Lymphoma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage III Adult Burkitt Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Immunoblastic Large Cell Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Adult T-cell Leukemia/Lymphoma;   Stage III Colon Cancer;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage III Rectal Cancer;   Stage III Small Lymphocytic Lymphoma;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Adult Burkitt Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Immunoblastic Large Cell Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Adult T-cell Leukemia/Lymphoma;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome;   Stage IV Rectal Cancer;   Stage IV Small Lymphocytic Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific;   Waldenström Macroglobulinemia
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Drug: capecitabine;   Other: laboratory biomarker analysis
39 Completed Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients
Condition: Tuberculosis
Intervention: Biological: V-5 immunitor
40 Completed Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Condition: Malaria
Interventions: Biological: GSK Biological's Investigational Malaria Vaccine 257049;   Biological: Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);;   Biological: Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine (Rabipur or equivalent) (Novartis).

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-43) Show next page of results    Last Page
Indicates status has not been verified in more than two years